SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001193125-06-047263
Filing Date
2006-03-07
Accepted
2006-03-07 17:06:16
Documents
9
Period of Report
2005-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K FOR THE YEAR ENDED DECEMBER 31, 2005 d10k.htm 10-K 1218981
2 SERVICES AGREEMENT dex1044.htm EX-10.44 115545
3 LIST OF SUBSIDIARIES dex211.htm EX-21.1 5677
4 CONSENT OF KPMG LLP dex231.htm EX-23.1 3017
5 CONSENT OF PRICEWATERHOUSECOOPERS, LLP dex232.htm EX-23.2 1752
6 CERTIFICATION OF CEO PURSUANT TO SECTION 302 dex311.htm EX-31.1 7988
7 CERTIFICATION OF CFO PURSUANT TO SECTION 302 dex312.htm EX-31.2 7884
8 CERTIFICATION OF CEO PURSUANT TO SECTION 906 dex321.htm EX-32.1 4203
9 BIOMARIN/GENZYME LLC, FINANCIAL STATEMENTS dex991.htm EX-99.1 190338
  Complete submission text file 0001193125-06-047263.txt   1556763
Mailing Address 105 DIGITAL DRIVE NOVATO CA 94949
Business Address 105 DIGITAL DRIVE NOVATO CA 94949 4155066700
BIOMARIN PHARMACEUTICAL INC (Filer) CIK: 0001048477 (see all company filings)

IRS No.: 680397820 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-26727 | Film No.: 06670742
SIC: 2834 Pharmaceutical Preparations